Yellow fever vaccination for immunocompromised travellers: unjustified vaccination hesitancy?

J Travel Med. 2019 Sep 2;26(6):taz015. doi: 10.1093/jtm/taz015.

Abstract

Improved quality of life in immunocompromised patients opens travel opportunities, but administering the yellow fever (YF) vaccine is often contraindicated. We advocate re-evaluating this position for immunocompromised patients who travel frequently or who are migrating to regions in which YF is endemic.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Contraindications, Drug
  • Enzyme Inhibitors / administration & dosage
  • Enzyme Inhibitors / adverse effects
  • Female
  • Humans
  • Immunocompromised Host / immunology*
  • Immunosuppressive Agents / administration & dosage
  • Immunosuppressive Agents / adverse effects
  • Male
  • Mycophenolic Acid / administration & dosage
  • Mycophenolic Acid / adverse effects
  • Risk Assessment
  • Tacrolimus / administration & dosage
  • Travel
  • Vaccination / adverse effects
  • Yellow Fever Vaccine / administration & dosage
  • Yellow Fever Vaccine / adverse effects
  • Yellow Fever Vaccine / immunology*

Substances

  • Enzyme Inhibitors
  • Immunosuppressive Agents
  • Yellow Fever Vaccine
  • Mycophenolic Acid
  • Tacrolimus